Enlighta Inc. announced a private placement of up to 1,239,733 common shares at a price of KRW 6,453 per common share for gross proceeds of up to KRW 7,999.997049 on December 20, 2023. The transaction is expected to close on December 28, 2023. The transaction included participation from returning investor, TELCON RF PHARMACEUTICAL.

Inc and new investor, Gencurix Inc. The offering is made on Third party allocation. The transaction is approved by board of directors.